Andrew Turitz - Mar 4, 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
SVP - Business Development
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Stock symbol
TDOC
Transactions as of
Mar 4, 2022
Transactions value $
-$89,027
Form type
4
Date filed
3/8/2022, 03:10 PM
Previous filing
Mar 4, 2022
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1.97K +17.04% 13.6K Mar 4, 2022 Direct F1
transaction TDOC Common Stock Options Exercise +2.57K +18.93% 16.1K Mar 4, 2022 Direct F2
transaction TDOC Common Stock Sale -$89K -1.33K -8.27% $66.74 14.8K Mar 7, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -1.97K -100% $0.00* 0 Mar 4, 2022 Common Stock 1.97K Direct F1, F4
transaction TDOC Performance Stock Units Options Exercise $0 -2.57K -100% $0.00* 0 Mar 4, 2022 Common Stock 2.57K Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards.
F4 On March 4, 2019, the reporting person was granted 5,922 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
F5 On February 26, 2020, the reporting person earned 7,701 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020.